RESTORE Patent Rights Act of 2024 – An Attempt To Bring Back Permanent Injunctions. Permanently.

Over the summer, Congressman Nathaniel Moran (R-TX-01), a member of the House Judiciary Subcommittee on Courts, Intellectual Property, and the Internet, and Congresswoman Madeleine Dean (D-PA-04) introduced the bicameral Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive (RESTORE) Patent Rights Act of 2024.

This bipartisan bill aims to restore patentees’ abilities to protect their patent rights through permanent injunctions, altered by the eBay v. MercExchange ruling.[1]

eBay v. MercExchange

The Supreme Court altered the landscape of permanent injunctions in patent cases in its 2006 eBay ruling. Before eBay, permanent injunctions issued once infringement and validity had been found. They were automatic and were only denied in “unusual cases.” The Court found that this automatic issuance violated the equitable determination that usually accompanies permanent injunctions. The Court ruled a patentee plaintiff must demonstrate the following before a permanent injunction issues:

(1) that it has suffered an irreparable injury;

(2) that remedies available at law, such as monetary damages, are inadequate to compensate for that injury;

(3) that, considering the balance of hardships between the plaintiff and defendant, a remedy in equity is warranted; and

(4) that the public interest would not be disserved by a permanent injunction.

 

In ruling this way, the Court disconnected a patent owner’s right to exclude from the remedy for stopping the violation of that right. Since eBay, permanent injunctions issue much more rarely.

 

The RESTORE Patent Rights Act

 

The RESTORE Patent Rights Act proposes to codify the pre-eBay injunction landscape. The Act proposes a relatively simple change to §283 whereby a rebuttable presumption would exist that a permanent injunction should issue if infringement is found. The Act states:

 

If, in a case under this title, the court enters a final judgment finding infringement of a right secured by patent, the patent owner shall be entitled to a rebuttable presumption that the court should grant a permanent injunction with respect to that infringing conduct.[2]

 

The authors of the bill worry that post eBay, a patentee’s exclusive right to his patented invention is meaningless, as permanent injunctions are no longer automatic.  The authors state that post-eBay requests for permanent injunctions in patent cases fell by 65% for companies that use their patented technology to manufacture a product and grants of permanent injunctions to those companies also fell by more than 65%.[3]

 

While the Act is still in its early stages, it appears to have bi-partisan support. We will continue to monitor developments and provide further insight if permanent injunctions become a more-powerful tool in the plaintiff’s toolbox and a detriment to defendants.

 

[1] eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388, 393, 126 S. Ct. 1837, 1840, 164 L. Ed. 2d 641 (2006)

[2] https://moran.house.gov/uploadedfiles/restore_act_2024.07.29.pdf

[3] https://www.coons.senate.gov/imo/media/doc/restore_act_one-pager.pdf


Trademark Q3 2024 updates, data at a glance

Trends in First Action Pendency at the USPTO

As many may be familiar with, in recent years trademark pendency times at the USPTO have rapidly increased, with the average first action pendency time in Q1-Q4 of 2023 reaching over 8 months. The USPTO attributes this increase in pendency times primarily to the fact that it expected a slowdown in patent and trademark filings in 2020 and 2021 during the COVID pandemic (and so adjusted hiring targets downward), while actually seeing a substantial increase in trademark filings (as more people started their own companies or launched new products based on new and different opportunities for e-commerce and remote work).

The trend that has led to a near-quadrupling of pendency times started in Q4 2020, with the average pendency time for most of 2019-2020 being consistently around 2.5 to 3 months, as can be seen in the graph below.

 

Average First Action Pendency Q3 2019 – Q2 2022

After Q4 2020 first action pendency began to increase markedly, reaching an average time of 7.7 months in Q2 2022 and then further increasing to a height of 8.5 months in Q2 2023.

 

Average First Action Pendency Q4 2021 – Q3 2024

In 2024, it seems that the USPTO has begun to be able to clear this “inherited backlog,” with Q3 2024 being the first time first action pendency has dropped below 8 months since Q2 2022.

 

Year to Date New Applications and Registrations

So far this year, there have been 338,915 new registrations and 564,474 new applications filed across all classes, which is an increase in 2.9% from filings in the same time period of 2023.

Applications in each quarter of the year have slightly increased from the low point in filings that occurred in 2023, though they still remain less than filings in 2021 and 2022.

Overall, the increase in pendency and decrease in filings from the last two years appears to be reversing course, though it remains to be seen whether either trend will continue back to pre-pandemic norms.  Maier & Maier includes experienced trademark counsel who can help with trademark filings and strategies based on the newest data and trends.


USPTO Terminating After Final Consideration Pilot (AFCP) Program 2.0

The USPTO will publish a notice in the Federal Register on October 1, 2024, stating that it will no longer accept AFCP 2.0 requests after December 14, 2024.

The current AFCP program (AFCP 2.0) was adopted in May of 2013.  The AFCP program is an attempt to reduce the number of requests for continued examination (RCEs) by providing an alternative pathway for resolution of applications under final rejection.  AFCP 2.0 is a pilot program that has been extended periodically and was most recently extended until September 30, 2024.  The AFCP 2.0 program does not require an additional fee.

The USPTO published a notice of proposed rulemaking in April of 2024 proposing to charge a $500 fee ($200 small entity, and $100 micro entity) for an ACFP 2.0 request (among other patent fee proposals).  The USPTO indicated that it now receives more than 60,000 AFCP 2.0 requests annually and that its costs to administer AFCP 2.0 are significant.  The USPTO advised that it may not renew the AFCP 2.0 program absent a fee to recover its cost.

The notice to be published on October 1, 2024 states that the AFCP 2.0 program will be terminated effective December 14, 2024, that day being the last day to submit an AFCP 2.0 request.  The notice explains that the comments received in response to the April 2024 fee proposal indicates the public is not widely receptive to paying a fee to participate in AFCP 2.0.  Thus, the USPTO is terminating the AFCP 2.0 program, but is providing a short extension until December 14, 2024 to accommodate those in the process preparing to use the AFCP 2.0 program.

The notice to be published on October 1, 2024 also sets out the after final options that remain available to applicants:  (1) filing an after final amendment under 37 CFR 1.116; (2) requesting an interview with the examiner, and/or (3) filing a notice of appeal with a request for a pre-appeal brief review request.


The AIA Grace Period: Not Your Parent’s Grace Period

The U.S. Court of Appeals for the Federal Circuit (Federal Circuit) recently issued a decision interpreting one of the exception provisions in AIA U.S.C. § 102(b), namely subsection (b)(2)(B). Sanho Corp. v. Kaijet Tech. Int’l, 108 F.4th 1376 (Fed. Cir. 2024).  The patentee in Sanho Corp. sought to disqualify a U.S. Patent Application Publication to another (Kuo) that was “effectively filed”[1] prior to the effective filing date of the claimed invention (i.e., was prior art under section 102(a)(2) but for an exception).  The patentee sought to invoke the prior art exception in section 102(b)(2)(B) on the basis of a private sale by the inventor occurring before the “effectively filed” date of Kuo.

The patentee argued that this prior private sale of the relevant subject matter by the inventor meant that the subject matter was “publicly disclosed” by the inventor because a private sale is considered a “disclosure” (prior art) under section 102(a)(1) per Helsinn.[2]  Prior to Helsinn, the USPTO’s 2013 guidelines stated that it “views the ‘or otherwise available to the public’ residual clause of the AIA’s 35 U.S.C. § 102(a)(1) as indicating that secret sale or use activity does not qualify as prior art” (and set out a lengthy explanation for that position).[3]  That is, prior to Helsinn, the USPTO did not view activity that did not result in the subject matter being “publicly disclosed” (such as a secret sale or use) as prior art or a “disclosure” under section 102(a)(1).[4]  The U.S. Supreme Court, however, held in Helsinn that “an inventor’s sale of an invention to a third party who is obligated to keep the invention confidential can qualify as prior art under § 102(a).”[5]  The patentee in Sanho Corp. thus argued that the prior private sale—equated to a public disclosure of the subject matter under Helsinn—meant that “the subject matter disclosed [in Kuo] had, before such subject matter was effectively filed under [section 102](a)(2), been publicly disclosed by the inventor [through the private sale] . . . ,” disqualifying Kuo as prior art per the section 102(b)(2)(B) exception.

The Federal Circuit, however, rejected the argument that placing subject matter “on sale” under section 102(a)(1) means that the subject matter is necessarily “publicly disclosed” for purposes of section 102(b)(2)(B).  The Federal Circuit drew a distinction between “disclosure” in subparagraph (A) of sections 102(b)(1) and (b)(2), and “publicly disclosed” in subparagraph (B) of sections 102(b)(1) and (b)(2).  The Federal Circuit stated that the section 102(b)(1)(A) exception applies to “disclosures” covered by section 102(a)(1), and the section 102(b)(2)(A) exception applies to “disclosures” covered by section 102(a)(2).  Thus, a private or public sale under section 102(a)(1) by the inventor occurring during the grace period is covered by section 102(b)(1)(A).  The Federal Circuit, however, held that the section 102(b)(1)(B) exception does not apply to “disclosures” under section 102(a)(1) that do not result in the subject matter being “publicly disclosed.”

Sanho Corp. is just one illustration that the AIA subparagraph (B) exception provision of sections 102(b)(1)[6] and (b)(2) cannot be viewed as functioning like showing prior invention under the former first to invent system.  There are a number of other significant differences between this subparagraph (B) exception provision and showing prior invention under the former first to invent system.

One of these differences is that the “subject matter” “disclosed” in subparagraph (B) of sections 102(b)(1) and (b)(2) relates to the subject matter being disqualified as prior art, not to the claimed invention.[7]  According to the USPTO, showing prior disclosure of the claimed invention may not be sufficient to disqualify intervening prior art.[8]  It is not clear if the courts will agree with this interpretation, but the USPTO’s guidance requires that the subject matter sought to be disqualified and the subject matter previously “publicly disclosed” by the inventor be identical (i.e., the exception does not reach to non-identical subject matter even if the differences amount to mere insubstantial changes, or trivial or obvious variations).[9] The USPTO’s guidance provides as an example that prior public disclosure of a species can disqualify a subsequent intervening grace period disclosure of a genus, but that a prior public disclosure of a genus would not be able to disqualify the subsequent intervening grace period of a species, making that species disclosure available as prior art under section 102(a)(1).[10]

Another one of these differences is that while section 102(b)(2) has no express grace period requirement, there is a de facto “one year” limitation with respect to its subparagraph (B) provision.  If the prior art (subject matter in a U.S. patent or published application) to be disqualified under subparagraph (B) of section 102(b)(2) was effectively filed more than one year before the effective filing date of the claimed invention, it would require a showing that the inventor “publicly disclosed” that subject matter more than one year before the effective filing date of the claimed invention.  In this situation, the inventor’s own public disclosure of that subject matter is itself prior art under section 102(a)(1) that is outside the one year grace period of section 102(b)(1).[11]  This de facto one year or grace period limitation: i.e., whether prior invention took place before or after the grace period, did not exist when showing prior invention to antedate U.S. patents and published applications that otherwise qualify as prior art under pre-AIA 35 U.S.C. § 102(e).

Sanho Corp. is only the first decision to deal with the subparagraph (B) provision of section 102(b)(1) or (b)(2), and the courts may or may not agree with the USPTO’s guidance on that provision.  What is clear is that this provision does not operate in the manner of antedating prior art under the former first to invent system.  The USPTO received comments suggesting that it should treat a prior public disclosure as if it were a provisional application.[12]  The better answer here is self-help: if one wants a public disclosure to be treated as a provisional application, one should concurrently file the disclosure in a provisional application.

[1] Section 102(d) defines when subject matter in a patent or published application is considered to have been “effectively filed” for purposes of section 102(a)(2).  Both the Kuo U.S. application filing date (February 17, 2017) and priority date (December 13, 2016) are before the Sanho Corp effective filing date (April 27, 2017) and also after the private sale date (November 17, 2016).

[2] Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., 586 U.S. 123 (2019).

[3] Examination Guidelines for Implementing the First Inventor To File Provisions of the Leahy-Smith America Invents Act, 78 Fed. Reg. 11059, 11060, 11061-63 (Feb. 14, 2013) (FITF Guidelines).

[4] The USPTO’s 2013 guidelines did not treat a private or secret sale as amounting to the subject matter of the sale being “publicly disclosed” under the subparagraph (B) provision of section 102(b)(1) or (b)(2) likely because the USPTO did not (in 2013) consider such a sale as being prior art or a “disclosure” under 35 USC 102(a)(1) in the first place.

[5] Helsinn, 586 U.S. at 132.  Possibly portending its decision in Looper Bright Enterprises, Helsinn does not even mention the USPTO’s prior interpretation of the “on sale” provision of AIA section 102(a)(1) (or an amicus brief by Congressman Lamar Smith, the “Smith” of the Leahy-Smith America Invents Act).  The USPTO issued a memorandum in response to Helsinn removing the requirement that “the sale must make the invention available to the public” from its guidance to examiners concerning the phrase “on sale” in section 102(a)(1)).

[6] Sanho Corp. involved 35 U.S.C. 102(b)(2)(B), but the wording of the subparagraph (B) provision of sections 102(b)(1) and (b)(2) differ only in that subparagraph (B) of section 102(b)(1) states “disclosure” in place of “subject matter was effectively filed under subsection (a)(2).”

[7] See FITF Guidelines, 78 Fed Reg. at 11077 (the subparagraph (B) provision “does not involve a comparison of the subject matter of the claimed invention to either the subject matter disclosed by the inventor . . . or to the subject matter of the subsequent intervening grace period disclosure”).  While not at issue, Sanho Corp. speaks in term of comparing the subject matter asserted to have been publicly disclosed by the inventor and both the prior art (Sanho Corp., 108 F.4th at 1380 n.3 (“[w]e do not reach this issue, but assume, without deciding, that Sanho is correct that the HyperDrive [subject of the sale] embodied the relevant teaching of Kuo that were asserted against the ’429 patent”) and Sanho Corp., 108 F.4th at 1385 (“the sale of the HyperDrive here did not publicly disclose the subject matter relied on from Kuo as required by section 102(b)(2)(B)”)) and the invention (Sanho Corp., 108 F.4th at 1385 (“even if we assume, see supra n.3, that the device did embody the subject matter of the invention”)).  This interchanging of the subject matter of Kuo and the subject matter of the invention is likely due to the identity of the relevant subject matter of Kuo and the invention.

[8] Sanho Corp. discusses AIA floor debates while also questioning their pertinence.  There are floor statements that can be cited to support the argument that once the inventor has publicly disclosed the invention, subsequent disclosures do not constitute prior art.  Sanho Corp., 108 F.4th at 1383 (discussing statement of Sen. Jon Kyl).  Either side of the argument will be able to find friends in the crowd.  FITF Guidelines, 78 Fed. Reg. at 11085 n.34 (discussing various legislative materials on the subparagraph (B) provision).  Nonetheless, the subparagraph B provision of sections (b)(1) and (b)(2) does not itself mention the “invention” or “claimed invention”: i.e., its “subject matter” goes to the subject matter of the prior art (“(2)—A disclosure shall not be prior art to a claimed invention under [section 102](a)(2) if— . . . (B) the subject matter disclosed had, before such subject matter was effectively filed under [section 102](a)(2), been publicly disclosed by the inventor. . . ;”).

[9] FITF Guidelines, 78 Fed. Reg. at 11061(“[t]hese examination guidelines maintain the identical subject matter interpretation of AIA 35 U.S.C. 102(b)(1)(B) and 102(b)(2)(B)”).  The guidelines, however, do not apply a verbatim or ipsissimis verbis requirement, and allow for different modes of disclosure and for subject matter sought to be disqualified to be a more general description of the subject matter previously “publicly disclosed” by the inventor.

[10] FITF Guidelines, 78 Fed Reg. at 11077.

[11] Strictly speaking, section 102 does not by its terms prohibit the use of subparagraph (B) of section 102(b)(2) to disqualify section 102(a)(2) prior art that was effectively filed more than one year before the effective filing date of the claimed invention, or the use of subparagraph (B) of section 102(b)(1) or (b)(2) on the basis of the relevant subject matter being “publicly disclosed” by the inventor more than one year before the effective filing date of the claimed invention.  That course of action, however, would only change the grounds for unpatentability to section 102(a)(1) based on the inventor’s public own disclosure—outside the grace period—of the relevant subject matter. FITF Guidelines, 78 Fed. Reg. at 11076-77.

[12] FITF Guidelines, 78 Fed. Reg. at 11067.


New Proposal Requirements for Terminal Disclaimers Filed to Overcome Non-Statutory Double Patenting

The filing and recordation of an unnecessary terminal disclaimer has been characterized as an “unhappy circumstance” (MPEP 1490, citing In re Jentoft, 392 F.2d 633, 639 n.6 (CCPA 1968)). In an apparently “not significant” regulatory action, the USPTO is proposing a noteworthy change to terminal disclaimer requirements. 89 Fed. Reg. 40439-49 (May 10, 2024). The change being proposed would have profound effects on the prosecution of patent families and would turn the filing of even necessary terminal disclaimers into an even more unhappy circumstance. In essence, the proposed rule would require that a terminal disclaimer to overcome a non-statutory double patenting (NSDP) rejection also include a provision that the patent in which the disclaimer is filed (“target patent”) is no longer enforceable if that patent is or ever has been tied directly or indirectly by a terminal disclaimer to overcome NSDP to another patent (“reference patent”) that includes: (1) a claim that has been finally held unpatentable or invalid under 35 U.S.C. § 102 or 103 in a Federal court in a civil action or at the USPTO, or (2) a statutory disclaimer of a claim filed after any challenge based on 35 U.S.C. § 102 or 103 to that claim has been made.

Under today’s practice, applicants facing a NSDP rejection over a reference patent in the same patent family (applications/patents sharing a common priority date or a common patent term filing date) often file a terminal disclaimer (or ask that the requirement be held in abeyance) as a matter of course simply to remove the issue. The current consequences of a terminal disclaimer for patents in a common patent family are the need to maintain common ownership and possible effects on patent term adjustment. The consequences of filing a terminal disclaimer with the USPTO’s proposed provision – possible unenforceability of the entire patent if any claim in any reference patent is held invalid under 35 U.S.C. § 102 or 103 – are sufficiently concerning that any NSDP rejection must be carefully considered. Specifically, applicants will want to insist on a specific explanation of how each claim subject to a NSDP rejection is not patentably distinct from some claim of the reference patent to be assured that: (1) the NSDP rejection is sufficiently strong that filing the terminal disclaimer is the only way to obtain a patent on the rejected claims (i.e., an appeal would be futile); and (2) claims not properly subject to a NSDP rejection can be pursued in another application.

The USPTO is concurrently proposing a number of changes to patent fees, including tiered disclaimer fees that increase the later in prosecution the disclaimer is filed, and additional fees for continuing applications filed more than five years from the benefit date claimed under 35 U.S.C. § 120, 121, 365(c), or 386(c). The increasing disclaimer fees would appear to encourage filing of terminal disclaimers to resolve NSDP issues early in prosecution, but the USPTO’s terminal disclaimer proposal will encourage applicants to avoid filing any terminal disclaimer if at all possible, leading to terminal disclaimers being filed later in prosecution if filing a terminal disclaimer cannot be avoided. It is not clear what effect these two proposals will have on early resolution of double patenting issues, but it is clear that the proposed fee and disclaimer changes will result in an increase in the costs of obtaining patent coverage.

The USPTO’s proposed rule notice mentions a 37 CFR 1.182 option for removing a terminal disclaimer, and explains how in various examples the removal of a terminal under this procedure will determine whether or not a patent is considered to have “never been tied” to another patent by the terminal disclaimer. As discussed in the proposed rule, pre-existing USPTO guidance indicates that there is no means to remove or nullify a terminal disclaimer in an issued patent, but that a petition under 37 CFR 1.182 may be used to seek removal or nullification of a terminal disclaimer that is no longer necessary or was filed in error (MPEP 1490). The grant of a petition under 37 CFR 1.182, however, does not always assure that a patent will be considered as having “never been tied” to another patent by the terminal disclaimer (as discussed in the proposed rule), and the grant of such a petition is within the USPTO’s discretion. The only way for an applicant to ensure that a patent will not be subject to a terminal disclaimer containing this proposed provision is not filing one in the first place.

Applicants must consider prosecution of patent families (and other related patents that could form the basis of a NSDP), and not just the application subject to a NSDP rejection. An applicant cannot avoid double patenting by disclaiming the claims of the patent forming the basis of a NSDP rejection (reference patent). Eli Lilly & Co. v. Barr Labs., Inc., 251 F.3d 955, 968 n.5 (Fed. Cir. 2001)(“[a] patent owner cannot avoid double patenting by disclaiming the earlier patent”). Thus, the situation is already largely determined once the patent that may be the basis for a future double patenting rejection – the reference patent – is issued. Applicants contemplating possible continuing applications will need to consider the downstream effects of the claims in any potential reference patent. Applicants will want to avoid having distinct inventions, or possibly even separately patentable claims, in a single patent.  Applicants will be less inclined than they already are to challenge restriction requirements. In a previous rulemaking (ultimately withdrawn), the USPTO provided for applicant-suggested restrictions (72 Fed. Reg. 46740-41, 46842 (Aug. 21, 2007), to have been codified as 37 CFR 1.142(c)). Applicants may want to consider such an approach, even if not expressly provided for in the rules.

Finally, it is less than clear that this rule (if adopted) would survive court review. The USPTO relies on In re Van Ornum, 686 F.2d 937 (CCPA 1982), as authority for this type of requirement for a terminal disclaimer to overcome NSDP. Van Ornum addressed a specific requirement (common ownership) that was in place for a decade at the time of the challenge and adopted with the support of the patent community. Van Ornum, 686 F.2d at 945-46. The court-recognized practical effect of a terminal disclaimer is to create a situation equivalent to having the claims of all the patents tied together by terminal disclaimer(s) in one single patent. In re Braithwaite, 379 F.2d 594, 601 (CCPA 1967) (cited in Van Ornum). The CCPA considered the common ownership provision at issue in Van Ornum acceptable because a NSDP terminal disclaimer is to create a situation equivalent to having the claims of all the patents tied together by the terminal disclaimer in one single patent, and it is not permissible to assign separate claims of a single patent to different parties. Van Ornum, 686 F.2d at 948 (citing Pope v. Gormully, 144 U.S. 248 (1892)). There is no analogous statutory or judicial principle that all or some subset of claims in a patent are no longer enforceable if any claim of that patent is held invalid under 35 U.S.C. § 102 or 103; rather, the patent statutes and judicial rulings are to the contrary. To the USPTO’s credit, it is not shy in stating that its purpose is to address existing statutory provisions and judicial rules (the current state of the law), which it sees as impeding market entry. 89 Fed. Reg. at 40441 (middle column). This USPTO effort, however, may be unavailing as the Federal Circuit does not accept the view that the USPTO may effectively set aside its judicial rules (much less statutes) by regulation. Agilent Tech. v. Affymetrix, 567 F.3d 1366, 1375 (Fed. Cir. 2009)(“This court does not accept the PTO’s statement that is can ‘administratively set aside the judicially created rule of In re Spina.’ Judicial precedent is as binding on administrative agencies as are statutes”)(citing Rowe v. Dror, 112 F.3d 473, 479 n.2 (Fed. Cir. 1997)).


Maier & Maier Secures Victory At the International Trade Commission

April 22, 2024  – Maier & Maier PLLC is pleased to report that our clients Hikam America, Inc., Hikam Electrónica de México, S.A. de C.V., Hikam Tecnologia de Sinaloa, Hewtech Philippines Corp., Hewtech Philippines Electronics Corp., and Hewtech (Shenzhen) Electronics Co., Ltd. have been terminated from ITC Investigation No. 337-TA-1365.

The Firm represented six of the Respondents in an ITC Investigation in which they were accused by Shoals Technologies Group, LLC (“Shoals”) of infringing U.S. Patent No. 10,553,739 (“the ‘739 Patent”), which purportedly covers molded fuses used in solar installations.

On March 6, 2024, the presiding ALJ issued an Initial Determination (Order No. 20) granting Respondents’ motion for summary determination pursuant to Commission Rule 210.18(b) (19 CFR 210.18(b)). The ID found that under the proper claim construction, Shoals has not shown that genuine issues of material fact exist regarding whether Shoals has satisfied the technical prong of the domestic industry requirement with respect to the ’739 Patent.

On March 13, 2024, Shoals filed a petition for review of the ID. On March 26, 2024, Respondents and OUII each filed separate responses to Shoals’ petition for review of the ID.

On April 19, 2024, the Commission determined not to review the ID. Because Shoals has not satisfied the technical prong of the domestic industry requirement for the ’739 patent, the investigation is now terminated as to the ’739 patent with a finding of no violation.

Maier & Maier continues to enjoy consistent and favorable results in its litigation matters. The firm has obtained favorable results when defending clients accused of infringement by competitors as well as cases brought by patent assertion entities. This victory comes on the heels of another favorable decision in a District Court case earlier this month.

About Maier & Maier PLLC

Maier & Maier’s litigation team has been hard at work delivering positive results for clients. The Maier & Maier team continues to advocate on behalf of clients in federal courts, before the Patent Trial and Appeal Board, the Trademark Trial and Appeal Board, and the International Trade Commission.


Maier & Maier Obtains Grant of Summary Judgment of Invalidity Based on §101 Related to Wearable Technology

April 5, 2024 – Maier & Maier PLLC is pleased to report that we secured a victory for our client Firstbeat Technologies OY in a case involving a heart rate measuring apparatus incorporated into wearable technology. The case was originally filed by Polar Electro OY in the District of Delaware on November 7, 2011, but was eventually transferred to the District of Utah. In December of 2021, we argued our Motions for Summary Judgment (“MSJ”) before Judge Waddoups. Today, the Court issued a decision granting our MSJ that the claims of U.S. Patent No. 6,537,227 are invalid as abstract. See 1:17-cv-00139-CW, Dkt. 498. The case has now been dismissed and Judgment has been entered in favor of our client Firstbeat Technologies OY.

Maier & Maier continues to enjoy consistent and favorable results in its litigation matters. The firm has obtained favorable results when defending clients accused of infringement by competitors as well as cases brought by patent assertion entities. This victory comes on the heels of another favorable decision in an ITC 337 Investigation last month.

About Maier & Maier PLLC

Maier & Maier’s litigation team has been hard at work delivering positive results for clients. The Maier & Maier Team continues to advocate on behalf of clients in federal courts, before the Patent Trial and Appeal Board, Trademark Trial and Appeal Board, and the International Trade Commission.


Timothy Maier Recognized as one of Washington D.C.’s Top Lawyers 2024

Tim Maier was recently recognized based on peer review by Washington D.C.’s Top Lawyers Washington DC 2024 Edition.


Perspectives on USPTO Rulemaking

A Perspective on USPTO Rulemaking Following In re Chestek, by Maier & Maier partner Robert Bahr, has been published on IP Watchdog. The article discusses the notice-and-comment rulemaking procedures practiced by the USPTO and the impact of the recent Federal Circuit decision in In re Chestek. You can read the full article here.


Maier & Maier Recognized for New Addition by Managing IP

Managing IP has published an article highlighting the addition of key former government officials to three top tier firms, including Finnegan, Maier & Maier, and O’Melveny.

To read the article, click here.